# PHASEBIO PHARMACEUTICALS INC (PHASQ)

> Institutional ownership reported to the SEC as of Q4 2022, from Form 13F filings. Source: https://holderbook.com/stocks/PHASQ/

- Reporting holders: 5
- Reported value: $15.6K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DAFNA Capital Management LLC](https://holderbook.com/funds/1389933-dafna-capital-management-llc/) | $9.7K | 321,856 | 0.0% | 17 |
| [ACADIAN ASSET MANAGEMENT LLC](https://holderbook.com/funds/916542-acadian-asset-management-llc/) | $4.0K | 172,958 | 0.0% | 6 |
| [HAMILTON LANE ADVISORS LLC](https://holderbook.com/funds/1573767-hamilton-lane-advisors-llc/) | $1.0K | 34,208 | 0.0% | 1 |
| [IPG Investment Advisors LLC](https://holderbook.com/funds/1602237-ipg-investment-advisors-llc/) | $864 | 28,700 | 0.0% | 5 |
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $6 | 197 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2022 | 5 | $15.6K |
| Q3 2022 | 29 | $3.9M |
| Q2 2022 | 43 | $14.0M |
| Q1 2022 | 54 | $38.9M |
| Q4 2021 | 50 | $75.0M |
| Q3 2021 | 59 | $96.1M |
| Q2 2021 | 53 | $113.3M |
| Q1 2021 | 61 | $110.6M |
| Q4 2020 | 56 | $53.5M |
| Q3 2020 | 50 | $60.2M |
| Q2 2020 | 61 | $84.5M |
| Q1 2020 | 48 | $61.1M |